RATINGS CHANGES

AmerisourceBergen (ABC) was upgraded to overweight from equal-weight at Morgan Stanley. $89 price target. The industry should benefit from the election, Morgan said. 

Franklin Resources (BEN) was downgraded to sell from hold at Deutsche Bank. The valuation is less attractive, based on a $35 price target, Deutsche said. 

Chesapeake (CHK) was upgraded to hold from underperform at Jefferies. $5 price target. The company is on firmer financial footing, Jefferies said. 

CSX (CSX) was downgraded to market perform at BMO Capital. $35 price target. There is excess capacity in the truck market and cost savings are likely to decelerate, BMO said. 

Humana (HUM) was upgraded to overweight from neutral at JPMorgan. $202 price target. Underlying earnings power is improving, JPMorgan said. 

IBM (IBM) was upgraded to buy from neutral at Bank of America/Merrill Lynch. $185 price target. The company has multiple potential earnings levers, analysts said. 

Northrop Grumman (NOC) was upgraded to overweight from equal-weight at Barclays. $270 price target. The company is leveraged to higher overall spending, Barclays said. 

Oasis (OAS) was upgraded to buy from hold at Deutsche Bank. $16 price target. The company can benefit from lower crude oil prices, Deutsche said. 

Universal Display (OLED) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: OLED.

OneMain (OMG) was downgraded to equal-weight at Barclays. $19 price target. The valuation is less attractive, as the company slashed earnings guidance, Barclays said. 

Qualcomm (QCOM) was downgraded to equal-weight from overweight at Morgan Stanley. The valuation is less attractive, based on a $65 price target, Morgan said. 

ViaSat (VSAT) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: VSAT.

WellCare Health Plans (WCG) was downgraded to neutral from overweight at JPMorgan. $115 price target. The valuation is less attractive, as the company is facing new political risks, JPMorgan said. 

This article was written by a staff member of TheStreet.

If you liked this article you might like

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Does Walgreens Buying AmerisourceBergen Make Any Sense?

Does Walgreens Buying AmerisourceBergen Make Any Sense?

Watch: Jim Cramer Reacts to a Potential Walgreens AmerisourceBergen Deal

Watch: Jim Cramer Reacts to a Potential Walgreens AmerisourceBergen Deal

Dow Futures Are Plunging Again

Dow Futures Are Plunging Again